Allergic Reactions to Inhalant Glucocorticosteroids: A Hot Topic for Pneumologists and Allergologists

REFERENCES

• De Swarte R.D., Petterson R. Drug allergy. Allergic Diseases Diagnostic and Management, R. Petterson, L.C. Grammer, P. Grenberger. Lippincot-Raven, Philadelphia 1997; 317–412
   Google Scholar
• Guillot B. Adverse skin reactions to inhaled corticosteroids. Expert Opin. Drug Saf 2002; 1: 329
   Google Scholar
• Bryant D.H., Pepys J. Bronchial reactions to aerosol inhalant vehicle. Br. J. Med 1976; 1: 1319
   PubMed Web of Science ®Google Scholar
• Godin J., Malo J. Acute bronchocostrition caused by Beclovent and not Vanceril. Clin. All 1979; 9: 589
   Google Scholar
• Shim C.S., Williams M.H. Cough and wheezing after inhalation of beclomethasone dipropionate aerosol in asthma. Chest 1987; 91: 209
   Google Scholar
• Shim C.S., Williams M.H. Coughing and wheezing from beclomethasone dipropionate aerosol are absent after triamcinolone acetonide. Ann. Intern. Med 1987; 106: 703
   PubMed Web of Science ®Google Scholar
• Facchini G., Antonicelli L., Cinti B., Bonifazi F., Massei V. Paradoxical bronchospasm and cutaneous rash after metered-dose inhaled bronchodilators. Monaldi. Arch. Chest Dis 1996; 51(3)203
   Google Scholar
• Silvastri M., Kohtamaki K., Lehtonen L., Vidgren M., Wenz W. Tolerability of two surfactants in beclomethasone inhalation aerosol formulations in patients with asthma. Drug Invest 1992; 4: 315
   Google Scholar
• Charpin D., Beaupe A., Orehek J. Deep-inspiration induced bronchocostition: a mechanism for beclomethasone aerosol intolerance. Eur. J. Respir 1986; 64: 497
   Google Scholar
• Clark R.J. Exacerbation of asthma after nebulised beclomethasone dipropionate. Lancet 1986; 2: 575
   Web of Science ®Google Scholar
• Poh S.C., Wang Y.T. Severe bronchocostrition after inhalation of beclomethasone and budesonide. Sing. Med. J 1986; 27: 249
   Google Scholar
• McGivern D.V., McFarlane J.T. Severe bronchocostrition after inhalation of budesonide. Br. Med. J 1984; 288: 447
   PubMedGoogle Scholar
• Miranda A., Garcia J.J., Torres M.J., del Cano A., Rondon C., Aguillar F., Carmona M.J., Vega J.M. Bronchospasm reaction induced by inhaled budesonide (abstract). Allergy 1993; 48: 148
   Google Scholar
• Rajan T.V. The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation. Trends Immunol 2003; 24: 376, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Belsito D.V. A sherlockian approach to contact dermatitis. Dermatol. Clin 1999; 17: 712
   Web of Science ®Google Scholar
• Wilkinson S.M., English J.S.C., Mattey D.L. In vitro evidence of delayed-type hypersensitivity to hydrocortisone. Cont. Derma 1993; 29: 245
   Web of Science ®Google Scholar
• Scala E., Giani M., Pastore S., Pallotta S., Guerra E.C., Pirrotta L., Locanto M.L., Frezzolini A., DePità O., Puddu P. Distinct delayed T-cell response to betamethasone and penicillin G in the same patient. Allergy 2003; 58: 444
   Web of Science ®Google Scholar
• Boujnah-Kouadja A., Brandi E.I., Reuter G., Foussereau J. Allergy to 2 new corticoid molecules. Cont. Dermat 1984; 11: 87
   Web of Science ®Google Scholar
• Bircher A.J., Hirsbrunner P., Tschopp K., Wildermuth V. Allergic contact dermatitis from tixocortol pivalate in a nasal spray masquerading as infectious complication of sinusitis. J. Otorhinolaryng. Relat. Spec 1995; 57: 56
   Google Scholar
• Camarsa J.G., Malet A., Serra-Baldrich E., Luch M. Contact allergy to tixocotol pivalate. Cont. Dermat 1988; 19: 1247
   Web of Science ®Google Scholar
• Bircher A.J., Pelloni F., Langauer, Messner S., Muller D. Delayed hypersensitivity reactions to corticosteroids applied to mucous membranes. Br. J. Dermatol 1996; 135: 313, [CROSSREF]
   Web of Science ®Google Scholar
• Jelen G. Un noveau cas d’allergie au tixocortol pivalate. Allergiè croissèe avec l'hydrocotisone. Lettre de Gerda 1986; 3: 29
   Google Scholar
• Bircher A.J. Short induction phase of contact allergy to tixocortol pivalate. Cont. Dermat 1990; 22: 238, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hausen B.M., Fossereau J. The sensitizing capacity of tixocortol pivalate. Cont. Dermat 1988; 18: 64
   Web of Science ®Google Scholar
• Doble N. Reaction to beclomethasone dipropionate nasal spray. Br. Med. J 1985; 290: 518
   PubMedGoogle Scholar
• Tani A., Miyoshi H., Kanzaki T. Allergic contact dermatitis due to beclomethasone dipropionate in an inhalant for asthma. Cont. Dermat 2000; 43: 363
   PubMed Web of Science ®Google Scholar
• Cooper S.M., Shaw S. Contact allergy to beclomethasone dipropionate. Cont. Dermat 1998; 39: 271
   PubMed Web of Science ®Google Scholar
• Meding B., Dahlberg E. Contact allergy to budesonide in a nasal spray. Cont. Dermat 1986; 14: 254, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gamboa P.M., Jauregui I., Antepara I. Contact dermatitis from budesonide in a nasal spray without cross-reactivity to amcinonide. Cont. Dermat 1991; 24: 228, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jorro G., Rochina A., Morales C. Contact allergy to topical budesonide in a nasal spray. Cont. Dermat 1993; 28: 254, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sastre J., Ibanez M.D. Contact allergy to budesonide contained in a nasal spray. Allergy 1992; 47: 662
   Web of Science ®Google Scholar
• Peris–Tortajada A., Giner A., Perez C., Hernandez D., Basomba A. Contact allergy to topical budesonide. J. All. Clin. Immunol 1991; 87: 598
   Web of Science ®Google Scholar
• Faria A., Marote J., de Freitas C. Contact allergy to budesonide in a nasal spray. Cont. Dermat 1992; 27: 5
   Web of Science ®Google Scholar
• Isaksson M., Bruze M., Wihl J.A. Contact allergy to budesonide and perforation of the nasal septum. Cont. Dermat 1997; 37: 133, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Iglesias Cadarso A., Diaz C., Laguna J.J., Hernandez Weigand P. Allergic contact dermatomucositis to budesonide. J. All. Clin. Immunol 1994; 94: 560
   Web of Science ®Google Scholar
• Garcia Abujeta J.L., Fernandez L., Maquiera E., Picans I., Rodriguez F., Jerez J. Contact allergy to budesonide in an oral spray. Cont. Dermat 1995; 32: 253, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gonzalo Garijo M.A., Bobadilla Gonzales P. Cutaneous-mucosal allergic contact reaction due to topical corticosteroids. Allergy 1995; 50: 836
   Web of Science ®Google Scholar
• Pirker C., Misic P., Frosch P.J. Angioedema and dysphagia caused by contact allergy to inhaled budesonide. Cont. Dermat 2003; 49: 79
   Web of Science ®Google Scholar
• Held E., Ottevanger V., Petersen V.S., Weisman K. Perioral dermatitis in children receiving budesonide inhalation therapy. Eur. J. Ped. Dermatol 1995; 5: 144
   Google Scholar
• Auricchio L., Nino M., Suppa F. Contact sensitivity to budesonide in a child. Cont. Dermat 2000; 42: 359
   PubMed Web of Science ®Google Scholar
• Cunha A.P., Mota A.V., Barros M.A., Bonito-Victor A., Resende C. Corticosteroid contact allergy from a nasal spray in a child. Cont. Dermat 2003; 49: 277, [CROSSREF]
   Google Scholar
• Holmes P., Cowen P. Spongiotic (eczematous-type) dermatitis after inhaled budesonide. Austr. NZ. J. Med 1992; 22: 511
   PubMedGoogle Scholar
• Poon E., Fewings J.M. Generalized eczematous reaction to budesonide in a nasal spray with cross reactivity to triamcinolone. Austr. J. Dermatol 2001; 42: 37
   Google Scholar
• Capwell S., Reynold S., Shuttleworth D., Edwards C., Finlay A.Y. Purpura and dermal thining associated with high dose inhaled corticosteroids. Br. Med. J 1990; 300: 1551
   PubMedGoogle Scholar
• Isaksson I., Bruze M. Allergic contact dermatitis in response to budesonide reactivated by inhalation of the allergen. J. Am. Acad. Dermatol 2002; 46: 885, [CROSSREF]
   Web of Science ®Google Scholar
• Fuchs T., Uter W., Sprotte U. Generalisierte urtikaria durch budesonid-verzogerte, IgE-vermittelte sofortreaktion?. Allergologie 1991; 14: 238
   Google Scholar
• Lauerma A.I., Kistaala R., Makinen-Kiljiunen S., Haathela T. Allergic skin reaction after inhalation of budesonide. Clin. Exp. All 1993; 23: 233
   Web of Science ®Google Scholar
• Dooms-Goossens A. Clinical aspects of contact allergy to corticosteroids. Dermatology 1994; 189(Suppl 2)55
   PubMedGoogle Scholar
• Melamed J., Stone B., Beaucher W., Chelmsford M.A. Anaphylaxis and flushing after the administration of intranasal fluticasone propionate (abstract). J. All. Clin. Immunol 1996; 97: 350, [CROSSREF]
   Web of Science ®Google Scholar
• Wilkinson S.M., Beck M.H. Fluticasone propionate and mometasone furoate have a low risk of contact sensitization. Cont. Dermat 1996; 34: 366, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Venning V.A. Fluticasone propionate sensitivity in a patient with contact allergy to multiple corticosteroids. Cont. Dermat 1995; 33: 49
   Web of Science ®Google Scholar
• Goossens A., Huygens S., Matura M., Degreef H. Fluticasone propionate: a rare contact sensitizer. Eur. J. Dermatol 2001; 11: 34
   Web of Science ®Google Scholar
• Bos J.D., Meinerdi M.M. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol 2000; 9: 169
   Web of Science ®Google Scholar
• Bundgaard H. The possible implication of steroid-glyoxal degradation products in allergic reactions to corticosteroids. Arch. Pharm. Chem. Sci. Ed 1980; 8: 90
   Google Scholar
• Wilkinson S.M., Jones M.F. Corticosteroid usage and binding to arginine: determinants of corticosteroids hypersensitivity. Br. J. Dermatol 1996; 135: 230, [CROSSREF]
   Web of Science ®Google Scholar
• Wilkinson S.M., English J.S.C. Hydrocotisone sensitivity: clinical features of 59 cases. J. Am. Acad. Dermatol 1992; 27: 687
   Web of Science ®Google Scholar
• Wilkinson S.M., Cartwright P.H., English J.S.C. The significance of tixocortol pivalate positive patch tests in leg ulcer patients. Cont. Dermat 1990; 23: 121, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Corazza M., Mantovani L., Maraini C., Bacileri S., Virgili A. Contact sensitization to corticosteroids: an increased risk in long term dermatoses. Eur. J. Dermatol 2000; 10: 535
   Web of Science ®Google Scholar
• Reitamo S., Lauerma A.I., Stubb S., Kayhko K., Visa K., Forstrom L. Delayed hypersensitivity to topical corticosteroids. J. Am. Acad. Dermatol 1986; 14: 589
   PubMed Web of Science ®Google Scholar
• Knowles S.R., Uetrecht J., Shear N.H. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet 2000; 356: 1591, [CROSSREF]
   Web of Science ®Google Scholar
• Leanza W.J., Combere J.P., Rogers E.F., Pfister K. Aldehydes derived from cortisone and hydrocortisone. J. Am. Chem. Soc 1953; 76: 1694
   Web of Science ®Google Scholar
• Dooms-Goossens A. Is there a relation between contact allergy to alcohols and contact allergy to corticosteroids? Eur. J. Dermatol 1993; 3: 713
   Google Scholar
• Dooms-Goosssens A., Lepoittevin J.P., Vigand M. Simultaneous positive patch test reactions to ethanol and/or aldehydes and corticosteroids. Communication – Acts of 2^nd-Congress European Society of Contact Dermatitis Octeber, 1994; 14
   Google Scholar
• Smith-Pease C.K., Basketter D.A., Patlewicz G.Y. Contact allergy: the role of skin chemistry and metabolism. Clin. Exp. Dermatol 2003; 28: 183
   Web of Science ®Google Scholar
• Patel L., Clayton P.E., Addison G.M., Price D.A., David T.J. Adrenal function following topical steroid treatment in children with atopic dermatitis. Br. J. Dermatol 1995; 32: 955
   Google Scholar
• Morren M.A., Dooms-Goossens A. Corticosteroid allergy in children: a potential complication of atopic eczema. Eur. J. Dermatol 1994; 4: 109
   Web of Science ®Google Scholar
• Schoenmakers A., Vermorken A., Degreef H., Dooms-Gossens A. Corticosteroids or steroids allergy?. Cont. Dermat 1992; 26: 162
   Google Scholar
• Wilkinson S.M., English J.C.S. Hydrocortisone sensitivity: a prospective study of the value of tixocortol pivalate and hydrocortisone acetate as patch test markers. Cont. Dermat 1991; 25: 135
   Web of Science ®Google Scholar
• Dooms-Goosssens A. Identification of undected corticosteroid allergy. Cont. Dermat 1988; 18: 125
   Web of Science ®Google Scholar
• Degreef H., Dooms-Gooosens A. The new corticosteroids: are they effective and safe?. Dermatol. Clin 1993; 11: 160
   Web of Science ®Google Scholar
• Wolf M.E., Baxter J.D., Kollmann P.A., Lee D.L., Kuntz I.D., Bloom E., Matulich D.T., Morris J. Nature of steroid-glucocorticoid receptor interactions: thermodynamic analysis of the binding reaction. Biochemistry 1978; 17: 3208
   Web of Science ®Google Scholar
• Shroot B., Caron J.C., Ponec M. Glucocorticoid specific binding: structure –activity relationship. Br. J. Dermatol 1982; 107(Suppl 23)34
   Google Scholar
• Dooms-Goossens A., Morren M. Results of routine patch testing with corticosteroid series in 2073 patients. Cont. Dermat 1992; 26: 191
   Web of Science ®Google Scholar
• Coopman S., Degreef H., Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis to topical corticosteroids. Br. J. Dermatol 1989; 121: 34, [CROSSREF]
   Web of Science ®Google Scholar
• Lepoittevin J.P., Drieghe J., Dooms-Goossens A. Studies in patient with corticosteroid contact allergy. Understanding cross-reactivity. Arch. Dermatol 1995; 131: 37
   Google Scholar
• Noda H., Matsunaga K., Noda T., Abe M., Ohtani T., Shimizu Y., Ashi K., Noriyasu T., Masutani M., Ueda H. Contact sensitivity and cross-reactivity of budesonide. Cont. Dermat 1993; 28: 215
   Web of Science ®Google Scholar
• Dahlberg E., Thalen A., Brattsand R. Correlation between chemical structure, receptor binding and biological activity of some novel highly active 16–17(acetal-substituted) glucocorticoids. Mol. Pharmacol 1983; 25: 70
   Web of Science ®Google Scholar
• Isaksson M., Bruze M., Lepoittevin J.P., Goossens A. Patch testing with serial dilutions of budesonide, its R and S diastereomers, and potentially cross-reacting substances. Am. J. Cont. Dermat 2001; 12: 176
   Google Scholar
• Oh-i T. Contact dermatitis due to topical steroids with conceivable cross-reactions between topical steroid preparations. J. Dermatol 1996; 23: 208
   Google Scholar
• Wilkinson S.M., English J.S.C. Hydrocortisone sensitivity. An investigation into the nature of the allergen. Cont. Dermat 1991; 25: 181
   Google Scholar
• Wilkinson S.M., Hollis S., Beck M.H. Reactions to other corticosteroids in patients with allergic contact dermatitis from hydrocortisone Br. J. Dermatol 1995; 132: 771
   Web of Science ®Google Scholar
• Haynes R.C., Jr. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical steroids biosynthesis. The Pharmacological Basis of Theurapeutics 7, Gillman Goodman. McMillan Publishing, New York 1985; 1489
   Google Scholar
• Wilkinson S.M., Hollis S., Beck M. Reactions to other corticosteroids in patients with positive patch test reactions to budesonide. J. Am. Acad. Dermatol 1995; 33: 968, [CROSSREF]
   Web of Science ®Google Scholar
• Kitano Y. Hydrolisis of hydrocortisone-17-butyrrate-21-propionate by cultured human keratinocytes. Acta Dermatol. Venereol 1986; 66: 102
   Web of Science ®Google Scholar
• Stingeni L., Lisi P. Contact allergy to prednicarbate: frequency of positive reactions in consecutively patch tested patients. Cont. Dermat 1999; 40: 287
   PubMed Web of Science ®Google Scholar
• Goossens A., Matura M., Degreef H. Reactions to corticosteroids: some new aspects regarding cross-sensitivity. Cutis 2000; 65: 45
   Web of Science ®Google Scholar
• Lauerma A.I. Screening for corticosteroid contact hypersensitivity: comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone. Cont. Dermat 1991; 24: 130
   Google Scholar
• Balato N., Ayala F., Patruno C., Lembo G., Bianchi B., Foti C., Angelini G. Mometasone furoate is an alternative for corticosteroid sensitive patients. Communication—Acts of Congress “Clinical Dermatology 2000”. Giugno, Singapore 1998; 18–20
   Google Scholar
• Edsbacker S., Jonsson S., Lindberg C., Ryrfeldt A., Thalen A. Methabolic pathways of the topical glucocorticoid budesonide in man. Drug Metabol. Dispos 1983; 11: 596
   Web of Science ®Google Scholar
• Ferguson A.D., Emerson R.M., English J.S.C. Cross-reactivity patterns to budesonide. Cont. Dermat 2002; 47: 340
   Web of Science ®Google Scholar
• National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung and Blood Institute; National Institutes of Health, 1997. scaricabile da. http://www.nhlbl.nih.gov
   Google Scholar
• Sommer S., Wilkinson S.M., English J.S.C., Gawkrodger D.J., Green C., King C.M., Powell S., Samson J.R., Shaw S. Type IV hypersensitivity to betamethasone valerate and clobetasol propionate: results of a multicentre study. Br. J. Dermatol 2002; 147: 269, [CROSSREF]
   Web of Science ®Google Scholar
• Stoeck M., Riedel R., Hochhaus G., Hafner D., Masso J.M., Schmidt B., Hatzelman A., Marx D., Bundscuh D.S. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J. Pharmacol. Exp. Ther 2004; 309: 258, [CROSSREF]
   Web of Science ®Google Scholar
• Wilkinson S.M., Higgins B., Owen S., Mattey D., Woodcock A. An assessment of steroid hypersensitivity in asthma. Respir. Med 1997; 91: 233
   Web of Science ®Google Scholar
• Isakkson M., Bruze M., Hornbland Y., Svenonius E., Wihl J.A. Contact allergy to corticosteroids in asthma/rhinitis patients. Cont. Dermat 1999; 40: 327
   PubMed Web of Science ®Google Scholar
• Bennett M.L., Fountain J.M., McCarty M.A., Sherertz E.F. Contact allergy to corticosteroids in patients using inhaled or intranasal corticosteroids for allergic rhinitis or asthma. Am. J. Cont. Dermat 2001; 12: 196
   Google Scholar
• Emerson R.M., English J.S., Harrison T.W., Wisniewski A., Cooper S., Tattersfield A.E. Do inhaled corticosteroids cause type-IV hypersensitivity reactions in asthma or chronic obstructive pulmonary disease (COPD)?. Br. J. Dermatol 2000; 143(Suppl 57)51
   Google Scholar
• Kilpio K., Hannuksela M. Corticosteroid allergy in asthma. Allergy 2003; 58: 1135, [CROSSREF]
   Web of Science ®Google Scholar
• Dooms-Goossens A., Andersen K.E., Brandao F.M., Bruynzeel D., Burrows D., Camarsa J., Ducombs G., Frosch P., Hannuksela M., Lachapelle J.M., Lahti A., Mennè T., Wahlberg J.E., Wilkinson D.J. Corticosteroid contact allergy: an EECDRG multicentre study. Cont. Dermat 1996; 35: 44
   Web of Science ®Google Scholar
• Farage M.A., Bjerke D.L., Mahony C., Blackburn K.L., Gerberick G.F. Quantitative risk assessment for the induction of allergic contact dermatitis: uncertainty factors for mucosal exposure. Cont. Dermat 2003; 49: 147
   Web of Science ®Google Scholar
• Lauerma A., Rasanen L., Reinala T., Reitamo S. Lgerhans cells but not monocytes are capable of antigen presentation in vitro in corticosteroid contact hypersensitivity. Br. J. Dermatol 1990; 123: 705, [CROSSREF]
   Web of Science ®Google Scholar
• Faria A.M., Weiner H.L. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol 1999; 73: 164
   Web of Science ®Google Scholar
• Kelly H.W. Potential adverse effects of the inhaled corticosteroids. J. All. Clin. Immunol 2003; 112: 477, [CROSSREF]
   Google Scholar
• Whitemore S.E. Delayed systemic allergic reactions to corticosteroids. Cont. Dermat 1995; 32: 195
   Web of Science ®Google Scholar
• Demitsu T., Kosuge A., Yamada T., Usui K., Katayama H., Yaoita H. Acute generalized exanthematous pustolosis induced by dexamethasone injection. Dermatology 1996; 193: 58
   Web of Science ®Google Scholar
• Heeringa M., Zweers P., deMan R.A., deGroot H. Anaphylactic like reaction associated with oral budesonide. Br. Med. J 2000; 321: 927, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Polosa R., Prosperini G., Pintaldi L., Rey J.P., Colombrita R. Anaphylaxis after prednisone. Allergy 1998; 53: 331
   PubMed Web of Science ®Google Scholar
• Bircher A.J., Levy F., Langauer S., Lepoittevin J.P. Contact allergy to topical corticosteroids and systemic contact dermatitis from prednisolone with tolerance of triamcinolone. Acta Dermatol. Venereol 1995; 75: 495
   PubMed Web of Science ®Google Scholar
• Crijns M.B., Nater J.P., van Oosten F., van der Waalk P.G. Vasoconstrictor and the anti-inflammatory effects of seven corticosteroids. Cont. Dermat 1984; 11: 111
   Web of Science ®Google Scholar
• Wilkinson S.M., Beck H.M. Corticosteroids contact hypersensitivity: what vehicle and concentration?. Cont. Dermat 1996; 34: 308
   Web of Science ®Google Scholar
• Isaksson M., Bruze M., Leipottevin J.P. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time. Cont. Dermat 1999; 40: 31, [CROSSREF]
   Web of Science ®Google Scholar